Vytrus Biotech, S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 2.39 million compared to EUR 1.6 million a year ago. Net income was EUR 0.335259 million compared to EUR 0.224454 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 EUR | +1.69% | +5.26% | +29.03% |
Apr. 03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.03% | 17.57M | |
-23.55% | 233M | |
-24.86% | 65.32M |
- Stock Market
- Equities
- VYT Stock
- News Vytrus Biotech, S.A.
- Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022